276 related articles for article (PubMed ID: 27670764)
21. Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition.
Li X; Kong X; Huo Q; Guo H; Yan S; Yuan C; Moran MS; Shao C; Yang Q
Cancer Sci; 2011 Jun; 102(6):1151-7. PubMed ID: 21371176
[TBL] [Abstract][Full Text] [Related]
22. Tiamulin inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of CD73.
Yang X; Pei S; Wang H; Jin Y; Yu F; Zhou B; Zhang H; Zhang D; Lin D
BMC Cancer; 2017 Apr; 17(1):255. PubMed ID: 28399915
[TBL] [Abstract][Full Text] [Related]
23. Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal.
Fang X; Cai Y; Liu J; Wang Z; Wu Q; Zhang Z; Yang CJ; Yuan L; Ouyang G
Oncogene; 2011 Nov; 30(47):4707-20. PubMed ID: 21602879
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts.
Liu S; Cong Y; Wang D; Sun Y; Deng L; Liu Y; Martin-Trevino R; Shang L; McDermott SP; Landis MD; Hong S; Adams A; D'Angelo R; Ginestier C; Charafe-Jauffret E; Clouthier SG; Birnbaum D; Wong ST; Zhan M; Chang JC; Wicha MS
Stem Cell Reports; 2014 Jan; 2(1):78-91. PubMed ID: 24511467
[TBL] [Abstract][Full Text] [Related]
25. Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer.
Zhang L; Xu L; Zhang F; Vlashi E
Cell Cycle; 2017 Apr; 16(8):737-745. PubMed ID: 27753527
[TBL] [Abstract][Full Text] [Related]
26. Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance.
Mallini P; Lennard T; Kirby J; Meeson A
Cancer Treat Rev; 2014 Apr; 40(3):341-8. PubMed ID: 24090504
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic efficacy and mechanism of CD73-TGFβ dual-blockade in a mouse model of triple-negative breast cancer.
Xing Y; Ren ZQ; Jin R; Liu L; Pei JP; Yu K
Acta Pharmacol Sin; 2022 Sep; 43(9):2410-2418. PubMed ID: 35082394
[TBL] [Abstract][Full Text] [Related]
28. CD73 as a therapeutic target for pancreatic neuroendocrine tumor stem cells.
Katsuta E; Tanaka S; Mogushi K; Shimada S; Akiyama Y; Aihara A; Matsumura S; Mitsunori Y; Ban D; Ochiai T; Kudo A; Fukamachi H; Tanaka H; Nakayama K; Arii S; Tanabe M
Int J Oncol; 2016 Feb; 48(2):657-69. PubMed ID: 26691441
[TBL] [Abstract][Full Text] [Related]
29. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
[TBL] [Abstract][Full Text] [Related]
30. Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer.
West NR; Murray JI; Watson PH
Oncogene; 2014 Mar; 33(12):1485-94. PubMed ID: 23584474
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles.
Jadidi-Niaragh F; Atyabi F; Rastegari A; Mollarazi E; Kiani M; Razavi A; Yousefi M; Kheshtchin N; Hassannia H; Hadjati J; Shokri F
Tumour Biol; 2016 Jun; 37(6):8403-12. PubMed ID: 26733167
[TBL] [Abstract][Full Text] [Related]
32. SURVIVIN as a marker for quiescent-breast cancer stem cells-An intermediate, adherent, pre-requisite phase of breast cancer metastasis.
Siddharth S; Das S; Nayak A; Kundu CN
Clin Exp Metastasis; 2016 Oct; 33(7):661-75. PubMed ID: 27411340
[TBL] [Abstract][Full Text] [Related]
33. Role of microRNAs in the regulation of breast cancer stem cells.
Liu S; Clouthier SG; Wicha MS
J Mammary Gland Biol Neoplasia; 2012 Mar; 17(1):15-21. PubMed ID: 22331423
[TBL] [Abstract][Full Text] [Related]
34. Mammospheres of hormonal receptor positive breast cancer diverge to triple-negative phenotype.
Laranjo M; Carvalho MJ; Costa T; Alves A; Oliveira RC; Casalta-Lopes J; Cordeiro P; Botas F; Abrantes AM; Paiva A; Oliveira C; Botelho MF
Breast; 2018 Apr; 38():22-29. PubMed ID: 29182983
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of SDF-1 activates the NF-κB pathway to induce epithelial to mesenchymal transition and cancer stem cell-like phenotypes of breast cancer cells.
Kong L; Guo S; Liu C; Zhao Y; Feng C; Liu Y; Wang T; Li C
Int J Oncol; 2016 Mar; 48(3):1085-94. PubMed ID: 26782945
[TBL] [Abstract][Full Text] [Related]
36. Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway.
Han D; Wu G; Chang C; Zhu F; Xiao Y; Li Q; Zhang T; Zhang L
Oncotarget; 2015 Dec; 6(38):40907-19. PubMed ID: 26517513
[TBL] [Abstract][Full Text] [Related]
37. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
[TBL] [Abstract][Full Text] [Related]
38. Elimination of epithelial-like and mesenchymal-like breast cancer stem cells to inhibit metastasis following nanoparticle-mediated photothermal therapy.
Paholak HJ; Stevers NO; Chen H; Burnett JP; He M; Korkaya H; McDermott SP; Deol Y; Clouthier SG; Luther T; Li Q; Wicha MS; Sun D
Biomaterials; 2016 Oct; 104():145-57. PubMed ID: 27450902
[TBL] [Abstract][Full Text] [Related]
39. Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells.
Shan S; Lv Q; Zhao Y; Liu C; Sun Y; Xi K; Xiao J; Li C
Int J Clin Exp Pathol; 2015; 8(10):12357-67. PubMed ID: 26722422
[TBL] [Abstract][Full Text] [Related]
40. RNA interference of ecto-5'-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion.
Zhi X; Chen S; Zhou P; Shao Z; Wang L; Ou Z; Yin L
Clin Exp Metastasis; 2007; 24(6):439-48. PubMed ID: 17587186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]